NCT01672996View on ClinicalTrials.gov

Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy
Interventions
DRUG

Ioforminol 160 mgI/mL

Given as s single administration to the subject

DRUG

Ioforminol 200 mgI/mL

Given as a single administration to the subject

DRUG

Iopamidol 300 mgI/mL

Given as a single administration to the subject

Trial Locations (1)

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
collaborator

Physician Reference Laboratory

UNKNOWN

collaborator

Quintiles, Inc.

INDUSTRY

lead

GE Healthcare

INDUSTRY

NCT01672996 - Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers | Biotech Hunter | Biotech Hunter